BriaCell Therapeutics Corp. (BCTXW) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は West Vancouver, BC, カナダ. 現CEOは William V. Williams.
BCTXW を有する IPO日 2012-08-13, 16 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $1.7K.
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
